| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/2005 | CN1572882A Benzamidine derivatives |
| 02/02/2005 | CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1572791A New benzothiazine and benzothiadiazine compounds, its preparation process and pharmaceutical composition containing said compounds |
| 02/02/2005 | CN1572790A New benzothiazine and benzothiadiazine compounds, its preparation process and pharmaceutical composition containing said compounds |
| 02/02/2005 | CN1572789A Use of certain crystal modifications of 1-(2, 6-difluorobenzyl)-1h-1, 2, 3-triazole-4-carboxamide in treating epilepsy |
| 02/02/2005 | CN1572337A Health gauze mask |
| 02/02/2005 | CN1572326A Therapeutic compositions including bio-availability enhancers |
| 02/02/2005 | CN1572320A Method for erythropoietin administration using pharmacokinetic and pharmacodynamic modeling |
| 02/02/2005 | CN1572318A Composition containing dipeptide of histidine and alanine for reducing uric acid |
| 02/02/2005 | CN1572304A Medicinal composition for treating diabetes mellitus containing ring Pro |
| 02/02/2005 | CN1572303A Methods and compositions for the prevention of tolerance to medications |
| 02/02/2005 | CN1572302A Application of avermectin containing parasite resistant pharmaceutical solid dispersion |
| 02/02/2005 | CN1572301A Tylosin containing antibiotic injection for animals |
| 02/02/2005 | CN1572300A Avermectin containing parasite resisitant long-acting injectio |
| 02/02/2005 | CN1572299A Agents for improving excretory potency of urinary bladder |
| 02/02/2005 | CN1572298A Arbidol containing compound preparation |
| 02/02/2005 | CN1572297A Application of berberine tannic acid in the preparation process of acute/chronic pharyngitis treating medicine |
| 02/02/2005 | CN1572296A Freeze dried vinpocetine powder injection and its preparation process |
| 02/02/2005 | CN1572295A Ischemic myocardial damage resistant usage of benzoisoselenothiazolidone compound |
| 02/02/2005 | CN1572294A Oral gliclazide sustained release formulation |
| 02/02/2005 | CN1572293A Legalon soft capsule and its preparing method |
| 02/02/2005 | CN1572147A Fat or oil composition |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187368C Carboxylic derivs. of diosgenin and process for preparing same |
| 02/02/2005 | CN1187367C 3 alpha-hydroxy-3 beta-methoxymethyl-21-heterocycle substd. steroids with anesthetic activity |
| 02/02/2005 | CN1187366C New 19-nor-pregene derivatives |
| 02/02/2005 | CN1187364C 类固醇衍生物 Steroid derivatives |
| 02/02/2005 | CN1187361C Phosphoric-acid substituted benzo-aza-tropone-N-acetic acid derivative, preparing method and medicine thereof |
| 02/02/2005 | CN1187358C Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 02/02/2005 | CN1187357C Calcarisporin B1 and extracting method and use in anti-tumor medicine |
| 02/02/2005 | CN1187354C Adenosine receptor antagonists and methods of making and using the same |
| 02/02/2005 | CN1187352C Phenanthroline-7-one derivs. and their therapeutic uses |
| 02/02/2005 | CN1187351C Bispidine compounds, their use and preparation method, intermediate and pharmaceutical compositions containing same |
| 02/02/2005 | CN1187350C Bispidine compounds, their use and preparation method, intermediate and pharmaceutical compositions containing same |
| 02/02/2005 | CN1187347C Chromatographic separation method of paclitaxel and cephalomannin |
| 02/02/2005 | CN1187343C Method for production of triazolinethione derivative |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/02/2005 | CN1187338C 5-phenyl-pyrimidine derivatives |
| 02/02/2005 | CN1187337C Thiobenzimidazole derivatives |
| 02/02/2005 | CN1187336C New imidazole derivatives |
| 02/02/2005 | CN1187333C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 02/02/2005 | CN1187331C Esters of 3-hydroxy-piperidinemethanol derivatives, pharmaceutical composition containing same and their preparation method and uses |
| 02/02/2005 | CN1187330C Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/02/2005 | CN1187318C Solid composition suitable for oral administration comprising non hydroscopic salts of L-carnitine or alkanoyl-L-carnitine with 2-aminoethanesulfonic acid |
| 02/02/2005 | CN1187312C Amorphous compounds and their pharmaceutical compositions |
| 02/02/2005 | CN1187106C Dual adhesive transdermal drug delivery system |
| 02/02/2005 | CN1187093C Composition for inhalation comprising delta-9-tetrahydrocannabinol in semiaqueous solvent |
| 02/02/2005 | CN1187090C Preventives/remedies for interstitial pneumonia and pulmonary fibrosis |
| 02/02/2005 | CN1187084C Use of alpha1 & beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease |
| 02/02/2005 | CN1187074C Medicine composite for treating cough and its preparation method |
| 02/02/2005 | CN1187073C Medicine composition for treating condyloma acuminatum and its prepation method |
| 02/02/2005 | CN1187070C Suppository for treating piles and other anorectal diseases and its preparation method |
| 02/02/2005 | CN1187069C Method for extracting coxtex mouten total glucoside for treating hepatitis |
| 02/02/2005 | CN1187065C Ointment for treating dermatopathy and preparing process thereof |
| 02/02/2005 | CN1187056C Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/02/2005 | CN1187055C Dioscin element medicine for treating myocardial ischemia, angina pectoris and cardiac infarction |
| 02/02/2005 | CN1187054C Osmosis pump controlled release preparation containing Chinese medicine of cyclovirobuxine D, and preparing method thereof |
| 02/02/2005 | CN1187053C Uses of sugar cortexin receptor antagon for production of phrenopathic medicine |
| 02/02/2005 | CN1187052C Sustained release microsphere containing stavudine |
| 02/02/2005 | CN1187051C Xanthine-based compound for preparation of medicine for enhancing insulin action |
| 02/02/2005 | CN1187050C Endothelin antogonist and a renin-angiotensin system inhibitor as a combined preparation |
| 02/02/2005 | CN1187049C Patches containing buprenorphine |
| 02/02/2005 | CN1187048C MGluR 5 antagonists for treatment of pain and anxiety |
| 02/02/2005 | CN1187047C Application of difenitriazole in preparation of medicine for treating malignant tumour |
| 02/02/2005 | CN1187046C Ketonic acid preparation for treating nephrosis |
| 02/02/2005 | CN1187045C Substances for use in treating psoriasis |
| 02/02/2005 | CN1187044C Storable active substance concentrate containing formoterol |
| 02/02/2005 | CN1187043C Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 02/02/2005 | CN1187042C Plaster which contains steroids and its production method and uses |
| 02/02/2005 | CN1187039C High potency dihydroergotamine compositions |
| 02/02/2005 | CN1187035C Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology |
| 02/02/2005 | CN1186983C Technique for detoxicating white spot syndrome virus of prawn |
| 02/01/2005 | US6849749 Method for the preparation of citalopram |
| 02/01/2005 | US6849746 Synthetic methods for polyphenols |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849737 Synthesis and purification of valacyclovir |
| 02/01/2005 | US6849736 Crystalline forms of valacyclovir hydrochloride |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849713 Topisomerase inhibitor |
| 02/01/2005 | US6849663 Particularly septic shock |
| 02/01/2005 | US6849662 Therapeutic uses for nitric oxide inhibitors |
| 02/01/2005 | US6849661 Including irritable bowel syndrome, infectious diseases of the small and large intestines, and symptoms of any of the foregoing using enriched (R)-verapamil |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/01/2005 | US6849657 Osteoporosis; increase bone density |
| 02/01/2005 | US6849655 Aqueous liquid formulations |
| 02/01/2005 | US6849654 Administering an effective amount of melatonin receptors (MT-3) agonists: 5-methoxy-carbonylamino-N-acetyltryptamine (5-MCA-NAT) or analogs thereof for therapy of depression, an obsessive compulsive disorder or anxiety in a human |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849651 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 02/01/2005 | US6849650 Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849647 Amide compounds and medications containing the same technical field |
| 02/01/2005 | US6849646 Chromenone and chromanone derivatives as integrin inhibitors |
| 02/01/2005 | US6849645 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
| 02/01/2005 | US6849644 For example, 7-(Indole-1-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline; treatment of depression, anxiety, Alzheimers disease, age related cognitive decline, Attention Deficit Disorder |
| 02/01/2005 | US6849643 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/01/2005 | US6849642 Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ring |